JP2024534824A5 - - Google Patents
Info
- Publication number
- JP2024534824A5 JP2024534824A5 JP2024511978A JP2024511978A JP2024534824A5 JP 2024534824 A5 JP2024534824 A5 JP 2024534824A5 JP 2024511978 A JP2024511978 A JP 2024511978A JP 2024511978 A JP2024511978 A JP 2024511978A JP 2024534824 A5 JP2024534824 A5 JP 2024534824A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- polypeptide
- identity
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163237071P | 2021-08-25 | 2021-08-25 | |
| US63/237,071 | 2021-08-25 | ||
| PCT/US2022/041471 WO2023038803A2 (en) | 2021-08-25 | 2022-08-25 | Engineered anti-her2 bispecific proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534824A JP2024534824A (ja) | 2024-09-26 |
| JP2024534824A5 true JP2024534824A5 (cg-RX-API-DMAC7.html) | 2025-08-28 |
Family
ID=85506758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024511978A Pending JP2024534824A (ja) | 2021-08-25 | 2022-08-25 | 操作された抗her2二重特異性タンパク質 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240392035A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4392064A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024534824A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118119402A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023038803A2 (cg-RX-API-DMAC7.html) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2706425A1 (en) * | 2007-11-27 | 2009-06-04 | Ablynx N.V. | Method for obtaining polypeptide constructs comprising two or more single domain antibodies |
| CN102378768A (zh) * | 2009-04-07 | 2012-03-14 | 罗氏格黎卡特股份公司 | 双特异性抗-ErbB-3/抗-c-Met抗体 |
| CA2832387A1 (en) * | 2011-04-20 | 2012-10-26 | Genmab A/S | Bispecifc antibodies against her2 |
| LT3074424T (lt) * | 2013-11-27 | 2025-05-26 | Zymeworks Bc Inc. | Bispecifiniai antigeną surišantys konstruktai, nukreipti į her2 |
| JP6510532B2 (ja) * | 2013-12-20 | 2019-05-08 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 二重特異性her2抗体及び使用方法 |
| CA2943299A1 (en) * | 2014-04-11 | 2015-10-15 | Medimmune, Llc | Bispecific her2 antibodies |
| CN110658340B (zh) * | 2015-01-08 | 2023-10-31 | 苏州康宁杰瑞生物科技有限公司 | 具有共同轻链的双特异性抗体或抗体混合物 |
| CN111094333A (zh) * | 2017-06-01 | 2020-05-01 | 斯图加特大学 | 异源二聚化的Ig结构域 |
| WO2019055841A1 (en) * | 2017-09-14 | 2019-03-21 | Denali Therapeutics Inc. | ANTI-TREM2 ANTIBODIES AND METHODS OF USE |
| CA3109763A1 (en) * | 2018-08-16 | 2020-02-20 | Denali Therapeutics Inc. | Engineered bispecific proteins |
| EP3840781A1 (en) * | 2018-08-22 | 2021-06-30 | Denali Therapeutics Inc. | Anti-her2 polypeptides and methods of use thereof |
| CA3170338A1 (en) * | 2020-02-19 | 2021-08-26 | Denali Therapeutics Inc. | Engineered anti-her2 bispecific proteins |
-
2022
- 2022-08-25 US US18/685,583 patent/US20240392035A1/en active Pending
- 2022-08-25 JP JP2024511978A patent/JP2024534824A/ja active Pending
- 2022-08-25 EP EP22867902.3A patent/EP4392064A4/en active Pending
- 2022-08-25 WO PCT/US2022/041471 patent/WO2023038803A2/en not_active Ceased
- 2022-08-25 CN CN202280063237.7A patent/CN118119402A/zh active Pending